Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer

Pancreatic cancer has one of the worst prognoses among all cancers due to the late manifestation of identifiable symptoms and high resistance to chemo- and radiation therapies. In recent years, a cancer development phase termed epithelial-mesenchymal transition (EMT) has gained increasing research f...

Descripción completa

Detalles Bibliográficos
Autores principales: Elaskalani, Omar, Razak, Norbaini Binti Abdol, Falasca, Marco, Metharom, Pat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241525/
https://www.ncbi.nlm.nih.gov/pubmed/28144398
http://dx.doi.org/10.4251/wjgo.v9.i1.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5241525/
https://www.ncbi.nlm.nih.gov/pubmed/28144398
http://dx.doi.org/10.4251/wjgo.v9.i1.37

Ejemplares similares